Hudson M. Holmes

Combining Commercial Cancer Protein Biomarkers and Benign Fungal Antibodies Improves Diagnostic Accuracy in Pulmonary Nodules.

OBJECTIVE: To evaluate whether adding cancer and histoplasma biomarkers to existing clinical prediction models improves diagnostic accuracy for malignancy in indeterminate pulmonary nodules (IPNs). SUMMARY BACKGROUND DATA: IPNs remain a diagnostic challenge, particularly in regio...